Treatment of Obsessive-Compulsive Syndromes in Schizophrenia

CNS Spectrums

Volumn 2, Issue 4, 1997, Pages 34-45

  Sasson, Yehuda ^a   Bermanzohn, Paul C ^b   Zohar, Joseph ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949937594     PISSN: 10928529     EISSN: 21656509     Source Type: Journal    
DOI: 10.1017/S1092852900004752     Document Type: Article

References (23)

1. Stengel, E. A study on some clinical aspects of the relationship between obsessional neurosis and psychotic reaction types. J Ment Science. 1945; 91: 166–187.
2. Rosen, I. The clinical significance of obsessions in schizophrenia. J Ment Science. 1957; 103: 773–788.
3. Fenton, WS, McGlashan, TH. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1986; 143: 437–441.
4. Berman, I, Kalinowski, A, Berman, SM, Lengua, J, Green, AL. Obsessive and compulsive symptoms in chronic schizophrenia. Compr Psychiatry. 1995; 36: 6–10.
5. Van Praag, HM, Asnis, GM, Kahn, RS, et al. Monoamines and abnormal behavior: a multi-aminergic perspective. Br J Psychiatry. 1990; 157: 723–734.
6. Anonymous, Treatment of syndromes of symptoms in psychiatry. Lancet. 1988; 2: 373–374. Editorial.
7. Yaryura-Tobias, JA, Neziroglu, MA, Bergman, L. Clomipramine for obsessive-compulsive neurosis: an organic approach. Curr Ther Res. 1976; 20: 541–548.
8. Stroebel, CF, Szarek, BL, Glueck, BC. Use of clomipramine in treatment of obsessive compulsive symptomatology. J Clin Psychopharmacol. 1984; 4: 98–100.
9. Zohar, J, Kaplan, Z, Benjamin, J. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients. J Clin Psychiatry. 1993; 54: 385–388.
10. Bark, N, Lindenmayer, JP. Ineffectiveness of clomipramine for obsessive compulsive symptoms in a patient with schizophrenia. Am J Psychiatry. 1992; 149: 136–137. Letter.
11. Zohar, J, Zohar-Kadouch, RC, Kindler, S. Current concepts in the pharmacological treatment of obsessive compulsive disorder. Drugs. 1992; 43: 210–218.
12. Silver, H, Nassar, A. Fluvoxamine improves negative symptoms in treated chronic schizophrenia: an add-on, double-blind, placebo-controlled study. Biol Psych. 1992; 31: 698–704.
13. Hwang, MY, Opler, LA. Schizophrenia with obsessive-compulsive features: assessment and treatment. Psychiatric Annals. 1994; 24(9).
14. Lindenmayber, JP, Vakharia, M, Kanofsky, D. Fluoxetine in chronic schizophrenia. J Clin Psychopharm. 1990; 1: 76. Letter.
15. Reznik, I, Sirota, P. Combined fluvoxamine and neuroleptic therapy for schizophrenic patients with obsessive compulsive disorder. Israel J Psychiatry. 1996; 33: 269–270.
16. Baker, RW, Chengappa, KNR, Baird, JW, Steingard, S, Christ, MAG, Schooler, NR. Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psych. 1992; 53: 439–441.
17. Patel, B, Tandon, R. Development of obsessive-compulsive symptoms during clozapine treatment. Am J Psychiatry. 1990; 150: 836. Letter.
18. Allen, L, Tejera, C. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline. Am J Psychiatry. 151: 1096–1097. Letter.
19. Siris, SG, Bermanzohn, PC, Mason, SE, Shuwall, MA. Maintenance imipramine for secondary depression in schizophrenia: a controlled trial. Arch Gen Psychiatry. 1994; 51: 109–115.
20. Siris, SG, Morgan, V, Fagerstrom, R, Rifkin, A, Cooper, TB. Adjunctive imipramine in the treatment of post-psychotic depression in schizophrenia: a controlled trial. Arch Gen Psychiatry. 1987; 44: 533–539.
21. Kramer, MS, Vogel, WH, DiJohnson, C, et al. Antidepressants in “depressed” schizophrenic inpatients: a controlled trial. Arch Gen Psychiatry. 1989; 46: 922–928.
22. Siris, SG. Adjunctive medications in the maintenance treatment of schizophrenia and their conceptual implications. Br J Psychiatry. 1993; 163: 66–78.
23. Pulman, J, Yassa, R, Anath, J. Clomipramine treatment of repetitive behavior. Can J Psychiatry. 1984; 29: 254–255.